2372.T
Price:
$2790
Market Cap:
$33.77B
I'rom Group Co., Ltd. engages in the advanced medicinal treatment, site management organization, contract research organization, and medical support businesses in Japan. The company engages in the development of medical technologies, such as regenerative medicine and gene therapy for obstructive arteriosclerosis, retinitis pigmentosa, and human immunodeficiency virus infection and acquired immune deficiency syndrome, as well as Sendai virus vector and CytoTune-iPS, a kit for generating iPS cells. It also supports medical institutions in conducting clinical trials; provides clinical trial support services for new drug development and medical equipment for cancer, and rare and intractable dise...[Read more]
Industry
Medical - Care Facilities
IPO Date
2005-02-01
Stock Exchange
JPX
Ticker
2372.T
According to I'rom Group Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 6.26%. This represents a change of 306.71% compared to the average of 1.54% of the last 4 quarters.
The mean historical ROE of I'rom Group Co., Ltd. over the last ten years is 9.43%. The current 6.26% ROE has changed -33.56% with respect to the historical average. Over the past ten years (40 quarters), 2372.T's ROE was at its highest in in the June 2017 quarter at 21.85%. The ROE was at its lowest in in the September 2015 quarter at -14.17%.
Average
9.43%
Median
15.41%
Minimum
-23.63%
Maximum
27.17%
Discovering the peaks and valleys of I'rom Group Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 483.78%
Maximum Annual ROE = 27.17%
Minimum Annual Increase = -119.70%
Minimum Annual ROE = -23.63%
Year | ROE | Change |
---|---|---|
2024 | 11.08% | -47.05% |
2023 | 20.93% | 8.26% |
2022 | 19.33% | 22.47% |
2021 | 15.78% | -8.50% |
2020 | 17.25% | 14.68% |
2019 | 15.04% | -44.64% |
2018 | 27.17% | 483.78% |
2017 | 4.65% | -119.70% |
2016 | -23.63% | 77.28% |
2015 | -13.33% | 101.59% |
The current ROE of I'rom Group Co., Ltd. (2372.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
17.11%
5-year avg
16.87%
10-year avg
9.43%
I'rom Group Co., Ltd.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like I'rom Group Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like I'rom Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is I'rom Group Co., Ltd.'s ROE?
How is the ROE calculated for I'rom Group Co., Ltd. (2372.T)?
What is the highest ROE for I'rom Group Co., Ltd. (2372.T)?
What is the 3-year average ROE for I'rom Group Co., Ltd. (2372.T)?
What is the 5-year average ROE for I'rom Group Co., Ltd. (2372.T)?
How does the current ROE for I'rom Group Co., Ltd. (2372.T) compare to its historical average?